(Q40908933)

English

Antitumor activity of mifepristone in the human LNCaP, LNCaP-C4, and LNCaP-C4-2 prostate cancer models in nude mice

scientific article

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

Antitumor activity of mifepristone in the human LNCaP, LNCaP-C4, and LNCaP-C4-2 prostate cancer models in nude mice (English)

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

1 reference

based on heuristic

inferred from title

author name string

El Etreby MF

1

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

Liang Y

2

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

Johnson MH

3

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

Lewis RW

4

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

publication date

1 February 2000

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

42

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

99-106

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

Antitumor activity of the antiprogestins ZK 98.299 and RU 38.486 in hormone dependent rat and mouse mammary tumors: mechanistic studies

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2820000201%2942%3A2%3C99%3A%3AAID-PROS3%3E3.0.CO%3B2-I

21 January 2018

Antitumor activity and mechanism of action of different antiprogestins in experimental breast cancer models

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2820000201%2942%3A2%3C99%3A%3AAID-PROS3%3E3.0.CO%3B2-I

21 January 2018

Progesterone antagonists: tumor-inhibiting potential and mechanism of action

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2820000201%2942%3A2%3C99%3A%3AAID-PROS3%3E3.0.CO%3B2-I

21 January 2018

The tumour-inhibiting potential of the progesterone antagonist Onapristone in the human mammary carcinoma T61 in nude mice

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2820000201%2942%3A2%3C99%3A%3AAID-PROS3%3E3.0.CO%3B2-I

21 January 2018

Effect of antiprogestins and tamoxifen on growth inhibition of MCF-7 human breast cancer cells in nude mice

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2820000201%2942%3A2%3C99%3A%3AAID-PROS3%3E3.0.CO%3B2-I

21 January 2018

Human hepatitis B virus and hepatocellular carcinoma I. Experimental infection of tree shrews with hepatitis B virus

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2820000201%2942%3A2%3C99%3A%3AAID-PROS3%3E3.0.CO%3B2-I

21 January 2018

Sex steroid receptors in normal and hyperplastic human prostate

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2820000201%2942%3A2%3C99%3A%3AAID-PROS3%3E3.0.CO%3B2-I

21 January 2018

Immunohistochemistry and biochemistry in detection of androgen, progesterone, and estrogen receptors in benign and malignant human prostatic tissue

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2820000201%2942%3A2%3C99%3A%3AAID-PROS3%3E3.0.CO%3B2-I

21 January 2018

Expression of estrogen receptor in diseased human prostate assessed by non-radioactive in situ hybridization and immunohistochemistry

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2820000201%2942%3A2%3C99%3A%3AAID-PROS3%3E3.0.CO%3B2-I

21 January 2018

Suppression of the growth of the androgen-insensitive R3327 HI rat prostatic carcinoma by combined estrogen and antiprogestin treatment

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2820000201%2942%3A2%3C99%3A%3AAID-PROS3%3E3.0.CO%3B2-I

21 January 2018

Growth inhibition of androgen-insensitive human prostate carcinoma cells by a 19-norsteroid derivative agent, mifepristone

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2820000201%2942%3A2%3C99%3A%3AAID-PROS3%3E3.0.CO%3B2-I

21 January 2018

A mutation in the ligand binding domain of the androgen receptor of human LNCaP cells affects steroid binding characteristics and response to anti-androgens

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2820000201%2942%3A2%3C99%3A%3AAID-PROS3%3E3.0.CO%3B2-I

21 January 2018

Derivation of androgen-independent human LNCaP prostatic cancer cell sublines: role of bone stromal cells

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2820000201%2942%3A2%3C99%3A%3AAID-PROS3%3E3.0.CO%3B2-I

21 January 2018

Decreased growth of established human prostate LNCaP tumors in nude mice fed a low-fat diet

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2820000201%2942%3A2%3C99%3A%3AAID-PROS3%3E3.0.CO%3B2-I

21 January 2018

Antitumor activity of the progesterone antagonists ZK 98.299 and RU 38.486 in the hormone-dependent MXT mammary tumor model of the mouse and the DMBA- and the MNU-induced mammary tumor models of the rat

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2820000201%2942%3A2%3C99%3A%3AAID-PROS3%3E3.0.CO%3B2-I

21 January 2018

The antitumor mechanism of progesterone antagonists is a receptor mediated antiproliferative effect by induction of terminal cell death

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2820000201%2942%3A2%3C99%3A%3AAID-PROS3%3E3.0.CO%3B2-I

21 January 2018

Progesterone antagonists block the growth of experimental mammary tumors in G0/G1

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2820000201%2942%3A2%3C99%3A%3AAID-PROS3%3E3.0.CO%3B2-I

21 January 2018

Enhancement of the antitumor efficacy of the antiprogestin, onapristone, by combination with the antiestrogen, ICI 164384

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2820000201%2942%3A2%3C99%3A%3AAID-PROS3%3E3.0.CO%3B2-I

21 January 2018

Additive effect of mifepristone and tamoxifen on apoptotic pathways in MCF-7 human breast cancer cells

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2820000201%2942%3A2%3C99%3A%3AAID-PROS3%3E3.0.CO%3B2-I

21 January 2018

Steroid receptors in metastatic carcinoma of the human prostate

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2820000201%2942%3A2%3C99%3A%3AAID-PROS3%3E3.0.CO%3B2-I

21 January 2018

Identifiers

10.1002/(SICI)1097-0045(20000201)42:2<99::AID-PROS3>3.0.CO;2-I

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40908933&oldid=2092463445"